Bishop J W, Kaufman R H, Taylor D A
Department of Pathology, Creighton University School of Medicine, Omaha, Nebraska 68131, USA.
Acta Cytol. 1999 Jan-Feb;43(1):34-8. doi: 10.1159/000330866.
To compare AutoCyte SCREEN-assisted evaluation of AutoCyte PREP liquid-based preparations with manual microscopic screening of the same preparations in a masked, multisite trial.
AutoCyte PREPs were made using the CytoRich automated, liquidbased method from the residual cellular material on the collection device after a conventional cervical smear had been made. The study involved 1,676 samples collected sequentially from high-risk patients at two medical centers. The AutoCyte PREPs were then screened manually by cytotechnologists at one of two laboratory sites. All abnormal slides were reviewed by the site pathologists for final diagnosis. The PREPs were then remasked and screened using the AutoCyte SCREEN automated, interactive screening system, designed to select potentially abnormal slides for manual review while allowing the direct sign-out of negative slides. The AutoCyte SCREEN-assisted practice result was determined by combining the interactive SCREEN result with manual evaluation for those cases selected by SCREEN for manual review. All slides deemed abnormal were manually reviewed by an independent reference pathologist. The original manual review results were then compared to the AutoCyte SCREEN-assisted practice results stratified by the Bethesda categories of abnormal diagnoses as determined by the reference pathologist.
Of the 1,676 cases, 494 were determined to be abnormal (ASCUS+) by one or both of the study methods and also by the independent reference pathologist. Of these 494 abnormal cases, 312 had a reference diagnosis of LSIL+, and 139 had a reference diagnosis of HSIL or cancer. The remainder of these cases were ASCUS or AGUS. Sensitivities and false negative proportions were stratified by the reference pathologist based on Bethesda categories as "truth" and compared. For LSIL+ cases, manual screening alone had a sensitivity of 89% as compared to 98% for the AutoCyte SCREEN-assisted practice. Manual screening demonstrated 90% sensitivity to HSIL or greater abnormality as compared to 99% sensitivity by the AutoCyte SCREEN-assisted practice.
There was a concurrent significant reduction in the false negative fraction using the AutoCyte SCREEN as part of screening practice. Specificity for both screening practices was equivalent.
在一项盲法、多中心试验中,比较AutoCyte SCREEN辅助评估AutoCyte PREP液基制剂与对相同制剂进行手动显微镜筛查的效果。
在进行常规宫颈涂片后,使用CytoRich自动化液基方法从采集装置上的残留细胞材料制备AutoCyte PREP。该研究涉及从两个医疗中心的高危患者中依次采集的1676份样本。然后,在两个实验室地点之一,由细胞技术专家对AutoCyte PREP进行手动筛查。所有异常玻片均由该地点的病理学家进行复查以做出最终诊断。随后对PREP重新进行盲法处理,并使用AutoCyte SCREEN自动化交互式筛查系统进行筛查,该系统旨在选择可能异常的玻片进行手动复查,同时允许直接签发阴性玻片。AutoCyte SCREEN辅助的实践结果是通过将交互式SCREEN结果与对SCREEN选择进行手动复查的那些病例的手动评估相结合来确定的。所有被认为异常的玻片均由独立的参考病理学家进行手动复查。然后将原始的手动复查结果与AutoCyte SCREEN辅助的实践结果进行比较,这些结果按参考病理学家确定的异常诊断的贝塞斯达分类进行分层。
在1676例病例中,494例通过一种或两种研究方法以及独立参考病理学家确定为异常(非典型鳞状细胞及以上)。在这494例异常病例中,312例参考诊断为低度鳞状上皮内病变及以上,139例参考诊断为高度鳞状上皮内病变或癌症。这些病例的其余部分为非典型鳞状细胞或非典型腺细胞。参考病理学家根据贝塞斯达分类将敏感性和假阴性比例分层为“真值”并进行比较。对于低度鳞状上皮内病变及以上病例,单独手动筛查的敏感性为89%,而AutoCyte SCREEN辅助实践的敏感性为98%。手动筛查对高度鳞状上皮内病变或更严重异常的敏感性为90%,而AutoCyte SCREEN辅助实践的敏感性为99%。
将AutoCyte SCREEN作为筛查实践的一部分,假阴性率同时显著降低。两种筛查实践的特异性相当。